Belite Bio to Present at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
SAN DIEGO, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Belite Bio, Inc. (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused...
PR News
Pin Retailer Chooses Bridgeline’s AI-Powered HawkSearch on BigCommerce
WOBURN, Mass., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Bridgeline Digital, Inc. (NASDAQ: BLIN), a global leader in AI-powered marketing technology,...
Leading online travel company Priceline and Sabre sign expanded, multi-year distribution agreement
The new relationship will focus on driving innovation and delivering superior content to travelers SOUTHLAKE, Texas, Aug. 8, 2024 /PRNewswire/...
Beneficient to Participate in the Sidoti Micro-Cap Conference on August 15, 2024
DALLAS, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Beneficient (NASDAQ: BENF) (“Ben” or the “Company”), a technology-enabled financial services holding company...
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
PALO ALTO, Calif., Aug. 08, 2024 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage...
Atlanta Braves Holdings Reports Second Quarter 2024 Financial Results
Contacts Shane Kleinstein (720) 875-5432 Atlanta Braves Holdings, Inc. (“ABH”) (Nasdaq: BATRA, BATRK) today reported second quarter 2024 results. Headlines...
Atlanta Braves Holdings Reports Second Quarter 2024 Financial Results
Contacts Shane Kleinstein (720) 875-5432 Atlanta Braves Holdings, Inc. (“ABH”) (Nasdaq: BATRA, BATRK) today reported second quarter 2024 results. Headlines...
Avnet Reports Fourth Quarter and Fiscal 2024 Financial Results
Fourth quarter sales of $5.6 billion and diluted EPS of $0.91 Adjusted diluted EPS of $1.22 Electronic Components operating margin...
Atlanticus Reports Second Quarter 2024 Financial Results
ATLANTA, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Atlanticus Holdings Corporation (NASDAQ: ATLC) (Atlanticus, the Company, we, our or us), a...
Sobi and Apellis announce positive topline results from phase 3 VALIANT study of pegcetacoplan in C3G and primary IC-MPGN
STOCKHOLM, Aug. 8, 2024 /PRNewswire/ -- Sobi® (STO: SOBI) and Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) today announced positive topline results...
All University Students Can Now Access Professional Coaching at No Cost
APUS and LifeRamp Partnership Enables ICF-Certified Coaching in Four Languages CHARLES TOWN, W.Va., Aug. 8, 2024 /PRNewswire/ -- Effective immediately,...
Adlai Nortye Reports Unaudited First Half 2024 Financial Results and Highlights Recent Operational Progress
SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Adlai Nortye Ltd. (NASDAQ: ANL) (the...
Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Allarity Therapeutics, Inc. (NASDAQ: ALLR) for potential violations of federal securities laws
NEW YORK, Aug. 8, 2024 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein"), a preeminent national shareholder...
Allogene Therapeutics Announces Participation in Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering...
AirSculpt Technologies Reports Second Quarter Fiscal 2024 Results
Second Quarter Revenue of $51.0 million, Net Loss of $3.2 million and Adjusted EBITDA of $6.9 millionRead more at globenewswire.com
Nauticus Robotics Enters Aquanaut Mark 2 Testing Partnership with FAU
HOUSTON, Aug. 8, 2024 /PRNewswire/ -- Nauticus Robotics, Inc. (NASDAQ: KITT), a leading innovator in subsea robotics and software, announces a...
Marin Software Extends Reach with Reddit and X Support
It’s never been easier for performance marketers and agencies to engage with their audience Contacts Media Contact: Wesley MacLaggan Marketing,...
SoundHound AI Reports 54% Growth and Record Q2 Revenue of $13.5 Million; Closes Quarter With Over $200 Million in Cash
Acquires Amelia, an enterprise conversational AI leader, to significantly expand to new verticals across finance, insurance, and healthcare Contacts Investors:...
The Honest Company Reports Second Quarter 2024 Results and Raises Full Year Outlook
Achieves Record Revenue of $93 million, up 10%Improved Profitability with Gross Margin of 38%, a 1,120 Basis Point IncreaseRaises Full...
Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Second Quarter and First Half 2024
Strong Momentum Continues for Amtagvi™ (Lifileucel) U.S. Launch with $31.1 Million in Total 2Q24 RevenueTotal Product Revenue Guidance of $53-$55...
SoundHound AI Acquires Amelia, Significantly Expanding Its Scale and Reach In Conversational AI Across New Verticals and Hundreds of Enterprise Brands
Amelia brings a strong legacy in enterprise AI along with customer service contracts from multinationals across finance, insurance, retail, and...
Personalis Reports Second Quarter 2024 Financial Results
Strong Revenue Growth of 35% Year-over-Year Driven by 117% Growth from Biopharma Business Raises 2024 Full Year Revenue Guidance Contacts...
DocGo Announces Strong Second Quarter 2024 Results
Company Raises Cash Flow From Operations Guidance to $80-$90 Million, Reiterates 2024 Revenue Guidance of $600-$650 Million and Adjusted EBITDA1...
Health Catalyst Finalizes Acquisition of Leading Care Management Company, Lumeon
SALT LAKE CITY, Aug. 8, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and...
GVP Investigation Alert: Halper Sadeh LLC Is Investigating Whether the Sale of GSE Systems, Inc. Is Fair to Shareholders
Contacts Halper Sadeh LLC Daniel Sadeh, Esq. Zachary Halper, Esq. (212) 763-0060 sadeh@halpersadeh.com zhalper@halpersadeh.com https://www.halpersadeh.com Halper Sadeh LLC, an investor...
Axogen, Inc. Announces New Leadership Appointments
ALACHUA, Fla. and TAMPA, Fla., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing...
Aldeyra Therapeutics Achieves Primary Endpoint in Phase 3 Dry Eye Disease Clinical Trial of Reproxalap
New Drug Application Resubmission Anticipated in 2024 Contacts Investor & Media: David Burke Tel: (917) 618-2651 investorrelations@aldeyra.com Aldeyra Therapeutics, Inc....
Expion360 Announces Closing of $10 Million Underwritten Public Offering
REDMOND, Ore., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Expion360 Inc. (Nasdaq: XPON) (“Expion360” or the “Company”), a lithium-ion battery power storage...
Altimmune Announces Second Quarter 2024 Financial Results and Provides a Business Update
Recent presentations at major medical meetings provide further support for the differentiated profile of pemvidutide in obesity and metabolic dysfunction-associated...
SkyWater Technology Reports Second Quarter 2024 Results
Eighth Straight Quarter of Record Revenue and 34% Growth Year-Over-Year Contacts SkyWater Investor Contact: Claire McAdams | claire@headgatepartners.com SkyWater Media...
Mullen Announces Its Dealer Eco Auto’s Expansion and Purchase of 180 Commercial EVs
Eco to purchase 130 Class 1 EV cargo vans and 50 Class 3 EV trucks over the next 18 months...
Clean Energy Reports Revenue of $98.0 Million and 57.1 Million RNG Gallons Sold for the Second Quarter of 2024
Contacts Media Contact: Gary Foster (949) 437-1113 Gary.Foster@cleanenergyfuels.com Investor Contact: Thomas Driscoll (949) 437-1191 Thomas.Driscoll@cleanenergyfuels.com Clean Energy Fuels Corp. (NASDAQ:...
Resolute Holdings to Acquire Majority Interest in CompoSecure with $372 million Personal Investment via David Cote Family
David Cote to Become Executive ChairmanTransaction Unlocks Value with Simplification of Corporate Structure Read more at globenewswire.com
Lucas GC Limited Announces US$6 Million Share Repurchase Program
NEW YORK, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Lucas GC Limited (NASDAQ: LGCL) (“Lucas” or the “Company”), an artificial intelligence...
ZyVersa Therapeutics Announces Published Data Supporting the Rationale for Inhibiting Inflammasome ASC with IC 100 to Control Chronic Inflammation
WESTON, Fla., Aug. 07, 2024 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA, or “ZyVersa”), a clinical stage specialty biopharmaceutical...
Zentek Announces Preliminary Battery Results and University of Toronto Receives NSERC Mission Alliance Grant to Optimize Graphite for Battery Anode Use
GUELPH, ON / ACCESSWIRE / August 8, 2024 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property technology...
Yatra Online, Inc. to Report First Quarter 2025 Financial Results on August 12, 2024
Contacts For further information, please contact: Manish Hemrajani Yatra Online, Inc. VP, Corporate Development and IR ir@yatra.com Yatra Online, Inc....
Xometry Reports Second Quarter 2024 Results
NORTH BETHESDA, Md., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Xometry, Inc. (NASDAQ:XMTR), the global AI-powered marketplace connecting enterprise buyers with...
X4 Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
First U.S. commercial sales of XOLREMDI™ (mavorixafor) following April 2024 FDA approvalPositive interim data from Phase 2 trial of mavorixafor...
Xeris Biopharma Reports Second Quarter 2024 Financial Results
Achieved revenue of $48.1M including record product revenue of $46.5M Total revenues increased 18% over the prior quarter and 26%...